Giuseppe Pastore
Overview
Explore the profile of Giuseppe Pastore including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
346
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fedele D, Cavallo D, Bodega F, Suma N, Canton L, Ciarlantini M, et al.
Heart
. 2024 Dec;
111(7):291-299.
PMID: 39689931
Background: Pathological mechanisms of myocardial infarction with non-obstructive coronary arteries (MINOCA) are heterogeneous, with an unknown impact on prognosis, and often remain unrecognised in clinical practice. This study aimed to...
2.
Amicone S, Impellizzeri A, Tattilo F, Ryabenko K, Asta C, Bela R, et al.
Echocardiography
. 2024 Oct;
41(10):e15953.
PMID: 39387111
Takotsubo syndrome (TTS) is a clinical syndrome characterized by a transient left ventricular dysfunction whose diagnosis can be challenging due to its resemblance to acute myocardial infarction (AMI). Despite the...
3.
Angeli F, Bergamaschi L, Armillotta M, Sansonetti A, Stefanizzi A, Canton L, et al.
Am J Cardiovasc Drugs
. 2024 Sep;
24(6):813-821.
PMID: 39240455
Background: In patients with atrial fibrillation (AF), the association between cancer and cardioembolic or bleeding risk during oral anticoagulant therapy still remains unclear. Purpose: We aimed to assess the impact...
4.
Angeli F, Bergamaschi L, Paolisso P, Armillotta M, Sansonetti A, Stefanizzi A, et al.
Heart Rhythm
. 2024 Jun;
22(1):240-249.
PMID: 38909718
Background: Cardiac masses represent a heterogeneous clinical scenario. Potential electrocardiographic (ECG) red flags of malignancy remain to be investigated. Objectives: The purpose of this study was to describe the spectrum...
5.
Robba C, Graziano F, Picetti E, Akerlund C, Addis A, Pastore G, et al.
Intensive Care Med
. 2024 Feb;
50(3):371-384.
PMID: 38376517
Purpose: We analysed the impact of early systemic insults (hypoxemia and hypotension, SIs) on brain injury biomarker profiles, acute care requirements during intensive care unit (ICU) stay, and 6-month outcomes...
6.
Correale M, Mazzeo P, Fortunato M, Paradiso M, Furore A, Fanizzi A, et al.
Clin Physiol Funct Imaging
. 2023 Oct;
44(1):112-117.
PMID: 37795627
Background: SGLT2 inhibitors have been shown to reduce hospitalisation in patients with chronic heart failure (CHF). The cardioprotective mechanisms of gliflozins however have not been fully elucidated. The aim of...
7.
Correale M, Mazzeo P, Mallardi A, Leopizzi A, Tricarico L, Fortunato M, et al.
Cardiovasc Drugs Ther
. 2021 Sep;
36(6):1157-1164.
PMID: 34519913
Purpose: The use of sodium-glucose-cotransporter-type-2 inhibitors (SGLT2i) was associated in previous studies with an improved vascular function in non-human experimental models. We therefore sought to evaluate possible changes in endothelial...
8.
Frazer P, Pastore G, McGarry A, Walsh T, Platt S
J Foot Ankle Surg
. 2021 Feb;
60(4):692-696.
PMID: 33546992
Research publication is a central to the scientific process and comprehensive bibliometric analysis is a leading way to better understand trends within research. Currently, there are limited bibliometric analyses of...
9.
Pastore G, Frazer P, McLean A, Walsh T, Platt S
ANZ J Surg
. 2020 Oct;
90(12):2549-2552.
PMID: 33021023
Background: The aim of this study was to conduct a readability analysis on both patient take-home information and consent forms for common foot and ankle procedures. Our hypothesis was that...
10.
Correale M, Leopizzi A, Mallardi A, Ranieri A, Suriano M, DAlessandro D, et al.
Thromb Res
. 2020 Jul;
195:16-20.
PMID: 32634728
Background: Chronic heart failure (CHF) is characterized by higher rates of atrial fibrillation (AF) and endothelial dysfunction (ED). First line anticoagulant therapy in AF is represented by direct oral anticoagulants...